Neonatal BCG vaccination induces IL-10 production by CD4+-CD25+ T cells

Pediatric Allergy and Immunology

Volumn 21, Issue 7, 2010, Pages 1059-1063

  Akkoc, Tunc ^a   Aydogan, Metin ^b   Yildiz, Aysegul ^a   Karakoc Aydiner, Elif ^a   Eifan, Aarif ^a   Keles, Sevgi ^a   Akin, Mustafa ^b   Kavuncuoglu, Sultan ^b   Bahceciler, Nerin N ^a   Barlan, Isil B ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b Bakirkoy Maternity and Child Hospital ^*  (Turkey)

Author keywords

Bacillus Calmette Guerin; Children; IFN ; IL 10; Purified protein derivative

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 5;

ARTICLE; BCG VACCINATION; CD4+ CD25+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; MALE; NEWBORN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T CELL DEPLETION; TH1 CELL; TUBERCULOSIS; UPREGULATION;

ANTIGENS, CD4; BCG VACCINE; CELLS, CULTURED; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE DEPLETION; MALE; T-LYMPHOCYTES, REGULATORY; TUBERCULIN; VACCINATION;

EID: 77958565901     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2010.01051.x     Document Type: Article

References (10)

1. World Health Organization. BCG vaccine. Wkly Epidemiol Rec 2004: 79: 25-40.
2. Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ 1990: 68: 93-108.
3. Sirinavin S, Chotpitayasunondh T, Suwanjutha S, Sunakorn P, Chantarojanasiri T. Protective efficacy of neonatal Bacillus Calmette-Guérin vaccination against tuberculosis. Pediatr Infect Dis J 1991: 10: 359-65.
4. Fine PE, Pönnighaus JM, Maine NP. The relationship between delayed type hypersensitivity and protective immunity induced by mycobacterial vaccines in man. Lepr Rev 1986: 57 (Suppl. 2): 275-83.
5. Soysal A, Millington KA, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005: 366: 1443-51.
6. Lalvani A, Bakir M, Millington KA, Dosanjh D, Soysal A. BCG and protection against Mycobacterium tuberculosis infection. Lancet 2006: 367: 391-2.
7. Yavuz T, Arbak P, Oztürk CE, Kocabay K. BCG vaccination: where are we now? Tuberk Toraks 2004: 52: 47-51.
8. Ildirim I, Sapan N, Cavusoǧlu B. Comparison of BCG vaccination at birth and at third month of life. Arch Dis Child 1992: 67: 80-2.
9. Nabeshima S, Murata M, Yamaji K, Chong Y, Nomoto M, Hayashi J. Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination. J Infect Chemother 2005: 11: 18-23.
10. Tastan Y, Arvas A, Demir G, Alikasifoǧlu M, Gür E, Kiray E. Influence of Bacillus Calmette-Guèrin vaccination at birth and 2-months old age on the peripheral blood T-cell subpopulations [gamma/delta and alpha-beta T cell]. Pediatr Allergy Immunol 2005: 16: 624-9.